Login / Signup
Nicole M Kettner
ORCID
Publication Activity (10 Years)
Years Active: 2023-2023
Publications (10 Years): 7
Top Topics
Circulating Tumor
Cell Free
Phase Iii
Metastatic Breast Cancer
Top Venues
Cancer research
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Tuyen Duong Thanh Nguyen
,
Yang Wang
,
Tuyen N Bui
,
Rossana Lazcano
,
Davis R Ingram
,
Min Yi
,
Varshini Vakulabharanam
,
Linjie Luo
,
Marc A Pina
,
Cansu Karakas
,
Mi Li
,
Nicole M Kettner
,
Neeta Somaiah
,
Peter J Houghton
,
Osama R Mawlawi
,
Alexander J F Lazar
,
Kelly K Hunt
,
Khandan Keyomarsi
Sequential targeting of retinoblastoma and DNA synthesis pathways is a therapeutic strategy for sarcomas that can be monitored in real-time.
Cancer research
(2023)
Tuyen Duong Thanh Nguyen
,
Yang Wang
,
Tuyen N Bui
,
Rossana Lazcano
,
Davis R Ingram
,
Min Yi
,
Varshini Vakulabharanam
,
Linjie Luo
,
Marc A Pina
,
Cansu Karakas
,
Mi Li
,
Nicole M Kettner
,
Neeta Somaiah
,
Peter J Houghton
,
Osama R Mawlawi
,
Alexander J F Lazar
,
Kelly K Hunt
,
Khandan Keyomarsi
Sequential Targeting of Retinoblastoma and DNA Synthesis Pathways Is a Therapeutic Strategy for Sarcomas That Can Be Monitored in Real Time.
Cancer research
83 (6) (2023)
Tuyen Duong Thanh Nguyen
,
Yang Wang
,
Tuyen N Bui
,
Rossana Lazcano
,
Davis R Ingram
,
Min Yi
,
Varshini Vakulabharanam
,
Linjie Luo
,
Marc A Pina
,
Cansu Karakas
,
Mi Li
,
Nicole M Kettner
,
Neeta Somaiah
,
Peter J Houghton
,
Osama R Mawlawi
,
Alexander J F Lazar
,
Kelly K Hunt
,
Khandan Keyomarsi
Sequential Targeting of Retinoblastoma and DNA Synthesis Pathways Is a Therapeutic Strategy for Sarcomas That Can Be Monitored in Real Time.
Cancer research
83 (6) (2023)
Tuyen Duong Thanh Nguyen
,
Yang Wang
,
Tuyen N Bui
,
Rossana Lazcano
,
Davis R Ingram
,
Min Yi
,
Varshini Vakulabharanam
,
Linjie Luo
,
Marc A Pina
,
Cansu Karakas
,
Mi Li
,
Nicole M Kettner
,
Neeta Somaiah
,
Peter J Houghton
,
Osama R Mawlawi
,
Alexander J F Lazar
,
Kelly K Hunt
,
Khandan Keyomarsi
Sequential Targeting of Retinoblastoma and DNA Synthesis Pathways Is a Therapeutic Strategy for Sarcomas That Can Be Monitored in Real Time.
Cancer research
83 (6) (2023)
Tuyen Duong Thanh Nguyen
,
Yang Wang
,
Tuyen N Bui
,
Rossana Lazcano
,
Davis R Ingram
,
Min Yi
,
Varshini Vakulabharanam
,
Linjie Luo
,
Marc A Pina
,
Cansu Karakas
,
Mi Li
,
Nicole M Kettner
,
Neeta Somaiah
,
Peter J Houghton
,
Osama R Mawlawi
,
Alexander J F Lazar
,
Kelly K Hunt
,
Khandan Keyomarsi
Sequential Targeting of Retinoblastoma and DNA Synthesis Pathways Is a Therapeutic Strategy for Sarcomas That Can Be Monitored in Real Time.
Cancer research
83 (6) (2023)
Tuyen Duong Thanh Nguyen
,
Yang Wang
,
Tuyen N Bui
,
Rossana Lazcano
,
Davis R Ingram
,
Min Yi
,
Varshini Vakulabharanam
,
Linjie Luo
,
Marc A Pina
,
Cansu Karakas
,
Mi Li
,
Nicole M Kettner
,
Neeta Somaiah
,
Peter J Houghton
,
Osama R Mawlawi
,
Alexander J F Lazar
,
Kelly K Hunt
,
Khandan Keyomarsi
Sequential Targeting of Retinoblastoma and DNA Synthesis Pathways Is a Therapeutic Strategy for Sarcomas That Can Be Monitored in Real Time.
Cancer research
83 (6) (2023)
Juliana Navarro-Yepes
,
Nicole M Kettner
,
Xiayu Rao
,
Cassandra Santaella Bishop
,
Tuyen N Bui
,
Hannah F Wingate
,
Akshara Singareeka Raghavendra
,
Yang Wang
,
Jing Wang
,
Ayşegül A Şahin
,
Funda Meric-Bernstam
,
Kelly K Hunt
,
Senthil Damodaran
,
Debasish Tripathy
,
Khandan Keyomarsi
Abemaciclib is effective in palbociclib-resistant hormone receptor-positive metastatic breast cancers.
Cancer research
(2023)